Brief: Catalyst Pharmaceuticals FY Revenue USD 589 Million Vs. IBES Estimate USD 578.4 Million
Feb 25 (Reuters) - Catalyst Pharmaceuticals FY net income USD 214.3 million. FY operating income USD 257.8 million outlook FY revenue USD 615-645 million
Feb 25 (Reuters) - Catalyst Pharmaceuticals FY net income USD 214.3 million. FY operating income USD 257.8 million outlook FY revenue USD 615-645 million